Related Topics News -

     
 Detail   |   Print    Next page > 
     
東陽光藥富馬酸伏諾拉生氯化鈉注射液上市申請獲受理
2026-04-08T  
《業績》東陽光藥全年虧轉盈賺2.72億人民幣
2026-03-31T  
《盈喜》東陽光藥預告扭虧 全年淨利潤2.7億人民幣
2026-03-13T  
東陽光藥針對尼帕病毒特效藥臨床試驗申請獲國家藥監局受理
2026-02-24T  
東陽光藥與晶泰控股訂戰略合作協議
2026-01-26T  
東陽光藥核心產品奧洛格列淨膠囊獲准上市
2026-01-18T  
東陽光藥推出PROTAC機制AI智能研發平台
2026-01-14T  
東陽光藥新藥HECN30227完成首例受試者入組
2026-01-05T  
東陽光藥控股股東集團成員間股權轉讓 料不會重大影響公司財務及營運
2025-12-30T  
東陽光藥有意購回股份
2025-11-25T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.